Next-Generation Vessel Assessment and Treatment Planning

A comprehensive system for assessing vessel blockages and planning personalized treatments, leveraging AI, machine learning, and digital twins to revolutionize the field of vascular medicine.

The original patent addressed the assessment of vessel blockages, but its limitations in accuracy, speed, and personalization hindered its adoption. The next-generation system overcomes these limitations by integrating AI-driven image analysis, machine learning-based fluid flow simulation, and digital twin technology to provide real-time, personalized vessel assessment and treatment planning.

The system comprises a neural network trained on a vast dataset of vessel images and corresponding fluid flow data, a fluid dynamics simulator, a database of vessel geometries and corresponding fluid flow patterns, and a search engine. The system generates a 3D model of the vessel from imaging data, analyzes it using machine learning algorithms to predict the severity of stenosis, and simulates various treatment scenarios to predict optimal treatment outcomes. The system also includes a device for in-vivo vessel assessment, comprising a catheter with an integrated sensor and a processing unit.

The novel combination of AI-driven image analysis, machine learning-based fluid flow simulation, and digital twin technology provides a paradigm shift in vessel assessment and treatment planning. The inventive concept's use of neural networks, fluid dynamics simulators, and digital twins enables real-time, personalized vessel assessment and treatment planning, making it a significant improvement over the original patent.

Alternative embodiments may include using different types of sensors, such as ultrasound or optical coherence tomography, or incorporating additional data sources, such as patient medical history or genetic information. Variations may also include adapting the system for use in different vascular regions, such as coronary or peripheral arteries.

The next-generation vessel assessment and treatment planning system has vast commercial potential in the medical device and healthcare industries, with potential applications in hospitals, clinics, and research institutions. The system's ability to provide personalized treatment plans and improve patient outcomes could revolutionize the field of vascular medicine and generate significant revenue.